Special AT-rich sequence-binding protein 2 (SATB2) in the differential diagnosis of osteogenic and non-osteogenic bone and soft tissue tumors
Open Access
- 13 September 2022
- journal article
- research article
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 56 (5) , 270-280
Abstract
Background: The diagnosis of osteosarcoma (OSA) depends on clinicopathological and radiological correlation. A biopsy is considered the gold standard for OSA diagnosis. However, since OSA is a great histological mimicker, diagnostic challenges exist. Immunohistochemistry (IHC) can serve as an adjunct for the histological diagnosis of OSA. Special AT-rich sequence-binding protein 2 (SATB2) was recently described as a reliable adjunct immunohistochemical marker for the diagnosis of OSA.Methods: We investigated the IHC expression of SATB2 in 95 OSA and 100 non-osteogenic bone and soft tissue tumors using a monoclonal antibody (clone EPNCIR30A). The diagnostic utility of SATB2 and correlation with clinicopathological parameters were analyzed.Results: SATB2 IHC was positive in 88 out of 95 cases (92.6%) of OSA and 50 out of 100 cases (50.0%) of primary non-osteogenic bone and soft tissue tumors. Of the 59 bone tumors, 37 cases (62.7%) were positive for SATB2, and of the 41 soft tissue tumors, 13 cases (31.7%) were positive for SATB2. The sensitivity of SATB2 as a diagnostic test was 92.6%, specificity 50%, positive predictive value 63.8%, and negative predictive value 87.7%.Conclusions: Although SATB2 is a useful diagnostic marker for OSA, other clinical, histological and immunohistochemical features should be considered for the interpretation of SATB2.Keywords
This publication has 18 references indexed in Scilit:
- Special AT‐rich sequence‐binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high‐grade primary bone sarcomasHistopathology, 2016
- Demographic profile of pediatric osteosarcoma in south India: A single institution experienceInternational Journal of Medical Research & Health Sciences, 2015
- Osteosarcoma: Diagnostic dilemmas in histopathology and prognostic factorsIndian Journal of Orthopaedics, 2014
- Further delineation of the SATB2 phenotypeEuropean Journal of Human Genetics, 2013
- Regulators of skeletal development: a cluster analysis of 206 bone tumors reveals diagnostically useful markersLaboratory Investigation, 2012
- Roles of SATB2 in Osteogenic Differentiation and Bone RegenerationTissue Engineering Part A, 2011
- Use of chemotherapy for patients with bone and soft-tissue sarcomasCleveland Clinic Journal of Medicine, 2010
- The nature of fibrous dysplasiaHead & Face Medicine, 2009
- Histogenetic Characterization of Giant Cell Tumor of BoneClinical Orthopaedics and Related Research, 2008
- Human giant cell tumors of bone identification and characterization of cell types.Journal of Clinical Investigation, 1987